These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 14648656)

  • 1. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
    Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
    J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
    Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
    Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
    Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.
    Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ
    Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma of the uterine cervix in Ireland and Sweden: human papillomavirus infection and biologic alterations.
    Skyldberg BM; Murray E; Lambkin H; Kelehan P; Auer GU
    Mod Pathol; 1999 Jul; 12(7):675-82. PubMed ID: 10430271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
    Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
    Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix.
    Tenti P; Pavanello S; Padovan L; Spinillo A; Vesentini N; Zappatore R; Migliora P; Zara C; Ranzani GN; Carnevali L
    Am J Pathol; 1998 Apr; 152(4):1057-63. PubMed ID: 9546366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship with human papilloma virus DNA in cervical adenocarcinoma].
    Ogura K; Ishi K; Suzuki F; Suto H; Kina K; Koyatsu J; Nojima M; Yoshida K; Suda K
    Rinsho Byori; 2004 Feb; 52(2):115-9. PubMed ID: 15027314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.
    Madeleine MM; Daling JR; Schwartz SM; Shera K; McKnight B; Carter JJ; Wipf GC; Critchlow CW; McDougall JK; Porter P; Galloway DA
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):171-7. PubMed ID: 11303584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
    Ferguson AW; Svoboda-Newman SM; Frank TS
    Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
    Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
    Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High sensitivity of PCR in situ hybridization for the detection of human papillomavirus infection in uterine cervical neoplasias.
    Xiao Y; Sato S; Oguchi T; Kudo K; Yokoyama Y; Saito Y
    Gynecol Oncol; 2001 Aug; 82(2):350-4. PubMed ID: 11531292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p16INK4a and MIB-1 in relation to histopathology and HPV types in cervical adenocarcinoma.
    Muller S; Flores-Staino C; Skyldberg B; Hellström AC; Johansson B; Hagmar B; Wallin KL; Andersson S
    Int J Oncol; 2008 Feb; 32(2):333-40. PubMed ID: 18202755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex nested PCR (MNP) assay for the detection of 15 high risk genotypes of human papillomavirus.
    Brestovac B; Harnett GB; Smith DW; Frost F; Shellam GR
    J Clin Virol; 2005 Jun; 33(2):116-22. PubMed ID: 15911426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix.
    Waggoner SE; Anderson SM; Van Eyck S; Fuller J; Luce MC; Herbst AL
    Obstet Gynecol; 1994 Sep; 84(3):404-8. PubMed ID: 8058239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of HPV 16/18 DNA in cervical adenocarcinoma using polymerase chain reaction (PCR) methodology.
    Johnson TL; Kim W; Plieth DA; Sarkar FH
    Mod Pathol; 1992 Jan; 5(1):35-40. PubMed ID: 1311838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas.
    Ogura K; Ishi K; Matsumoto T; Kina K; Nojima M; Suda K
    Pathol Int; 2006 Jun; 56(6):301-8. PubMed ID: 16704493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.